IP Library Granted Patent US 9,267,132
Granted Patent B2
US 9,267,132 · App. 12/783,489 · Granted Feb 23, 2016

Methods for cloning and manipulating genomes

Inventors: Gwynedd A. Benders (San Diego, CA); John I. Glass (Germantown, MD); Clyde A. Hutchison (La Jolla, CA); Carole Lartigue (Gaithersburg, MD); Sanjay Vashee (Boyds, MD); Mikkel A. Algire (Jessup, MD); Hamilton O. Smith (San Diego, CA); Charles E. Merryman (Sykesville, MD); Vladimir N. Noskov (Montgomery Village, MD); Ray-Yuan Chuang (Rockville, MD); Daniel G. Gibson (Crofton, MD); J. Craig Venter (La Jolla, CA)
Assignee: Synthetic Genomics, Inc.
C12N15/10C12N15/1031C12N15/1079C12N15/1093
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,267,132
App. No.
12/783,489
Granted
Feb 23, 2016
Kind
B2
Abstract

Compositions and methods are disclosed herein for cloning a synthetic or a semi-synthetic donor genome in a heterologous host cell. In one embodiment, the donor genome can be further modified within a host cell. Modified or unmodified genomes can be further isolated from the host cell and transferred to a recipient cell. Methods disclosed herein can be used to alter donor genomes from intractable donor cells in more tractable host cells.

Claims (32)

1. A method for creating a self-replicating synthetic cell, said method comprising:

(i) assembling a synthetic bacterial, cyanobacterial, or microalgal donor genome as one or more fragments and introducing the donor genome as one or more fragments and a host vector into a yeast host cell, wherein the donor genome and the host vector are joined prior to or after introduction into the yeast host cell;

(ii) recovering the assembled donor genome from the yeast host cell;

(iii) performing step a) or b) or c) wherein a), b) and c) comprise

a) preparing the donor genome for transplantation into a bacterial, cyanobacterial, or microalgal recipient cell by methylating the donor genome;

b) preparing a bacterial or cyanobacterial or microalgal recipient cell by removing or inactivating a restriction endonuclease function present in the recipient cell that cuts the donor genome;

c) providing a bacterial, cyanobacterial, or microalgal recipient cell lacking a restriction endonuclease function that cuts the donor genome; and

(iv) introducing the recovered donor genome into the recipient cell,

thereby generating a self-replicating synthetic cell comprising the donor genome and controlled only by the donor genome, wherein the donor genome is sufficient to sustain viability and continuous self-replication of the recipient cell; and

wherein the synthetic cell supports gene expression from the donor genome and has a phenotype of the donor genome,

wherein the donor genome is an essentially intact genome that is at least a minimal genome, and is greater than about 300 kb in length.

2. The method of claim 1 , wherein the donor genome and the host vector are introduced into the host cell simultaneously.

3. The method of claim 1 , wherein the donor genome and host vector are joined prior to introduction into the yeast host cell by transforming the yeast host vector into a donor cell containing the donor genome.

4. The method of claim 3 , wherein the host vector is a centromeric plasmid.

5. The method of claim 1 , wherein the donor genome is modified within the yeast host cell.

6. The method of claim 1 , further comprising degrading or removing the endogenous genome of the recipient cell.

7. The method of claim 1 , wherein the recovered donor genome is methylated prior to introduction into the recipient cell.

8. The method of claim 1 , wherein the recipient cell's restriction endonuclease function is absent, removed or inactivated.

9. The method of claim 1 , further comprising introducing a second donor genome into the host cell, wherein the second donor genome is different from the first donor genome, thereby producing a host cell containing two different donor genomes.

10. The method of claim 9 , wherein introducing the second donor genome comprises mating the host cell containing the first donor genome with a second host cell containing the second donor genome.

11. The method of claim 1 , wherein the synthetic cell exhibits a phenotype corresponding to the donor genome incorporating any modifications thereto.

12. The method of claim 1 wherein the synthetic donor genome is assembled in vitro prior to introducing the donor genome into the host cell.

13. The method of claim 5 wherein the modification of the donor genome is selected from the group consisting of a substitution, a deletion, an insertion, a rearrangement, and a recombination.

14. The method of claim 13 wherein the modification is selected from the group consisting of: an insertion, a deletion, and a substitution.

15. The method of claim 5 wherein the modification is a homologous recombination.

16. The method of claim 1 wherein the donor genome is a bacterial genome and the recipient cell is a bacterial cell.

17. The method of claim 1 wherein the donor genome is a cyanobacterial genome and the recipient cell is a cyanobacterial cell.

18. The method of claim 1 wherein the donor genome is a microalgal genome and the recipient cell is a microalgal cell.

19. The method of claim 1 wherein the yeast host cell is Saccharomyces cerevisiae or Saccharomyces pombe.

20. The method of claim 16 , wherein the donor genome is a Mycoplasma genome and the recipient cell is a Mycoplasma cell.

21. The method of claim 19 , wherein the recipient cell is a Mycoplasma capricolum.

22. The method of claim 20 , wherein the recipient cell is a Mycoplasma capricolum.

Assignments (11)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (TERM) Recorded Jul 16, 2024
From: MIDCAP FINANCIAL TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0070 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (REVOLVING) Recorded Jul 16, 2024
From: MIDCAP FUNDING IV TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2024
From: TELESIS BIO INC.
To: J. CRAIG VENTER INSTITUTE, INC.
Reel/Frame 066312/0643 →
CHANGE OF NAME Recorded Apr 19, 2023
From: CODEX DNA, INC.
To: TELESIS BIO INC.
Reel/Frame 063379/0581 →
SECURITY INTEREST (REVOLVING) Recorded Aug 18, 2022
From: CODEX DNA, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 061208/0063 →
SECURITY INTEREST (TERM) Recorded Aug 18, 2022
From: CODEX DNA, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061208/0080 →
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2020
From: OXFORD FINANCE LLC
To: SYNTHETIC GENOMICS, INC.; GENOVIA BIO, LLC; GREEN RESOURCES, LLC; SGI-DNA, INC.; SYNTHETIC GENOMICS VACCINES, INC.
Reel/Frame 054372/0822 →
CHANGE OF NAME Recorded May 19, 2020
From: SGI-DNA, INC.
To: CODEX DNA, INC.
Reel/Frame 052705/0893 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2019
From: SYNTHETIC GENOMICS, INC.
To: SGI-DNA, INC.
Reel/Frame 049602/0502 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2010
From: J. CRAIG VENTER INSTITUTE, INC.
To: SYNTHETIC GENOMICS, INC.
Reel/Frame 025068/0593 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2010
From: BENDERS, GWYNEDD A.; GLASS, JOHN I.; CHUANG, RAY-YUAN; HUTCHISON, CLYDE A.; LARTIGUE, CAROLE; VASHEE, SANJAY; ALGIRE, MIKKEL A.; SMITH, HAMILTON O.; VENTER, J. CRAIG; MERRYMAN, CHARLES E.; NOSKOV, VLADIMIR N.; GIBSON, DANIEL G.
To: J. CRAIG VENTER INSTITUTE, INC.
Reel/Frame 025068/0343 →
Continuity (5)
Continuation In Part 12718911 · Mar 5, 2010
Continuation In Part PCTUS2010026434 · Mar 5, 2010
Provisional Application 61158320 · Mar 6, 2009
Provisional Application 61322269 · Apr 8, 2010
Related Publication 20110053273A1 · Mar 3, 2011